Economic evaluation of the use of nadroparin calcium in the prophylaxis of deep vein thrombosis and pulmonary embolism in surgical patients in Italy

PharmacoEconomics

Volumn 12, Issue 4, 1997, Pages 475-485

  Lloyd, Adam ^a,b   Aitken, Judith A ^a   Hoffmeyer, Ullrich K O ^a   Kelso, Emma J ^a   Wakerly, Elizabeth C ^a,c   Barber, Nicholas D ^d  

^a NERA ECONOMIC CONSULTING   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; NADROPARIN;

ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEEP VEIN THROMBOSIS; ECONOMIC EVALUATION; HUMAN; ITALY; LUNG EMBOLISM; META ANALYSIS; PRIORITY JOURNAL; SURGICAL PATIENT;

EID: 0030854248     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199712040-00005     Document Type: Article

References (30)

1. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for thromboembolism in hospital palients. BMJ 1992; 305: 567-74
2. Prevention of venous thromboembolism: European consensus statement. Developed under the auspices of the Cardiovascular Disease Education and Research Trust: 1991 Nov 1-5: Windsor, Cyprus: Med-Orion Publishing Company, 1992
3. Wille-Jørgesen P. Prophylaxis of postoperative thrombocmbolisni. Dan Med Bull 1991; 38: 203-28
4. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgery patients. Ann Surg 1988; 208: 227-40
5. Collins R, Scrimgeour A, Yusut S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162-73
6. Drug Information Pharmacists Group. South West Thames Regional Drug Information Centre, New Product Assessment. Low-molecular-weight heparins. London: Drug Information Pharmacists Group, 1991
7. Hommes DW, Bura A. Mazzolai L, et al. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. Ann Intern Med 1992; 116: 279-84
8. Frydman AM, Bara L, Le Roux Y, et al. The antithiombotic activity and pharmacokinetics of enoxaparin, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 ml. J Clin Pharmacol 1988; 8: 609-18
9. Caen JP. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery, Thromb Haemost 1988; 59: 216-9
10. Deehavanne M, Ville D, Berruyer M, et al. Randomized trial of a low molecular weight heparin (Kabi 2165) versus adjusted dose subcutaneous standard heparin in the prophylaxis of deep vein thrombosis after elective hip surgery. Haemostasis 1989; 1: 5-12
11. Encke A, Breddin K. Comparison of a low molecular weight and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg 1988; 75: 1058-63
12. Eriksson BI, Eriksson E, Wudenvik H, et al. Comparison of low molecular weight heparin and unfractionated heparin in prophylaxis ot deep vein thrombosis and pulmonary embolism in total hip replacement [abstract]. Thromb Haemostas 1989; 62: 470
13. Fricker JP, Vergnes Y, Schach R, et al. Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophlyaxis of thromboernbolic complications of abdominal oncological surgery. Eur J Clin Invest 1988; 18: 561-7
14. Hartl P, Brücke P, Dienstl E, et al. Prophylaxis of thromboembolism in general surgery: comparison between standard heparin and Fragmin. Thromb Res 1990; 57: 577-84
15. Kakkar VV, Murray WJG. Efficacy and safety of low molecular weight heparin (CY216) in preventing postoperative thrombo-embolism: a cooperative study. Br J Surg 1985; 72: 786-91
16. Leyvraz PF, Postel M, Bachmann L, et al. Prevention of deep vein thrombosis after total hip replacement: randomized comparison between adjusted dose unfractionated heparin and low molecular weight heparin (CY216). In: Hoeck JA, editor. Deep vein thrombosis following total hip replacement. Amsterdam: University of Amsterdam, 1990
17. Planes A, Vochelle N, Mazas F, et al. Prevention of postoperative venous thrombosis: a randomized trial comparing untractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemostas 1988; 60: 407-11
18. Samania M, Bernard P, Bonnardot JP, et al. Low molecular weight heparin with unfractionated heparin in prevention of postoperative thrombosis. Br J Surg 1988; 75: 128-31
19. Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low molecular weight heparins versus standard heparins in general and orthopaedic surgery: a mela analysis. Lancet 1992; 340: 152-6
20. Leizorovicv A, Haugh MC, Chopuis ER, et al. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305 (6859): 913-20
21. Drummond M, Aristides M, Davies L, et al. Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgery. Br J Surg 1994; 81 (12): 1742-6
22. Borris LC, Lassen MR, Jensen HP, et al. Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery: clinical and economic considerations. Int J Clin Pharmacol Ther 1994; 32 (5): 262-8
23. Healon D, Pearce M. Low molecular weight versus unfractionaled heparin: a clinical and economic appraisal. Pharmacoeconomics 1995; 8 (2): 91-9
24. Anderson DR, O'Brien BJ, Lcvine MM, et al. Efficacy and cost of low molecular weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty. Ann Intern Med 1993; 119: 1105-12
25. Garattini L, Grilli R, Scopellili D, et al. A proposal for Italian guidelines in pharmacoeconomics. Pharmacoeconomics 1995; 7(1): 1-6
26. Nyman U. Diagnostic strategies in acute pulmonary embolism. Haemostasis 1993; 23 Suppl. 1: 220-6
27. Kakkar VV. Prevention of fatal pulmonary embolism. Haemostasis 1993; 23 Suppl. 1: 42-50
28. Law Dm n 80, 7 XI 1991, Gazzetta Ufficiale n 2876, Rome: Italian Government, 1991 Dec 6
29. Levine M, Gent M, Hirsch J, et al. A comparison of low-molecular weight heparin administered primarily at home with unfractionated heparin administered in hospital for proximal deep vein thrombosis. N Engl J Med 1996; 334 (11): 677-81
30. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med; 334(11): 682-7